
Taysha Gene Therapies Inc
NASDAQ:TSHA

Taysha Gene Therapies Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.27
4.17
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Taysha Gene Therapies Inc hold over its rivals?
What risks and challenges
does Taysha Gene Therapies Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Taysha Gene Therapies Inc.
Provide an overview of the primary business activities
of Taysha Gene Therapies Inc.
What unique competitive advantages
does Taysha Gene Therapies Inc hold over its rivals?
What risks and challenges
does Taysha Gene Therapies Inc face in the near future?
Has there been any significant insider trading activity
in Taysha Gene Therapies Inc recently?
Summarize the latest earnings call
of Taysha Gene Therapies Inc.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Taysha Gene Therapies Inc.
Provide P/S
for Taysha Gene Therapies Inc.
Provide P/E
for Taysha Gene Therapies Inc.
Provide P/OCF
for Taysha Gene Therapies Inc.
Provide P/FCFE
for Taysha Gene Therapies Inc.
Provide P/B
for Taysha Gene Therapies Inc.
Provide EV/S
for Taysha Gene Therapies Inc.
Provide EV/GP
for Taysha Gene Therapies Inc.
Provide EV/EBITDA
for Taysha Gene Therapies Inc.
Provide EV/EBIT
for Taysha Gene Therapies Inc.
Provide EV/OCF
for Taysha Gene Therapies Inc.
Provide EV/FCFF
for Taysha Gene Therapies Inc.
Provide EV/IC
for Taysha Gene Therapies Inc.
Show me price targets
for Taysha Gene Therapies Inc made by professional analysts.
What are the Revenue projections
for Taysha Gene Therapies Inc?
How accurate were the past Revenue estimates
for Taysha Gene Therapies Inc?
What are the Net Income projections
for Taysha Gene Therapies Inc?
How accurate were the past Net Income estimates
for Taysha Gene Therapies Inc?
What are the EPS projections
for Taysha Gene Therapies Inc?
How accurate were the past EPS estimates
for Taysha Gene Therapies Inc?
What are the EBIT projections
for Taysha Gene Therapies Inc?
How accurate were the past EBIT estimates
for Taysha Gene Therapies Inc?
Compare the revenue forecasts
for Taysha Gene Therapies Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Taysha Gene Therapies Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Taysha Gene Therapies Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Taysha Gene Therapies Inc compared to its peers.
Compare the P/E ratios
of Taysha Gene Therapies Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Taysha Gene Therapies Inc with its peers.
Analyze the financial leverage
of Taysha Gene Therapies Inc compared to its main competitors.
Show all profitability ratios
for Taysha Gene Therapies Inc.
Provide ROE
for Taysha Gene Therapies Inc.
Provide ROA
for Taysha Gene Therapies Inc.
Provide ROIC
for Taysha Gene Therapies Inc.
Provide ROCE
for Taysha Gene Therapies Inc.
Provide Gross Margin
for Taysha Gene Therapies Inc.
Provide Operating Margin
for Taysha Gene Therapies Inc.
Provide Net Margin
for Taysha Gene Therapies Inc.
Provide FCF Margin
for Taysha Gene Therapies Inc.
Show all solvency ratios
for Taysha Gene Therapies Inc.
Provide D/E Ratio
for Taysha Gene Therapies Inc.
Provide D/A Ratio
for Taysha Gene Therapies Inc.
Provide Interest Coverage Ratio
for Taysha Gene Therapies Inc.
Provide Altman Z-Score Ratio
for Taysha Gene Therapies Inc.
Provide Quick Ratio
for Taysha Gene Therapies Inc.
Provide Current Ratio
for Taysha Gene Therapies Inc.
Provide Cash Ratio
for Taysha Gene Therapies Inc.
What is the historical Revenue growth
over the last 5 years for Taysha Gene Therapies Inc?
What is the historical Net Income growth
over the last 5 years for Taysha Gene Therapies Inc?
What is the current Free Cash Flow
of Taysha Gene Therapies Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Taysha Gene Therapies Inc.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
US |
![]() |
Taysha Gene Therapies Inc
NASDAQ:TSHA
|
352.5m USD | 42.3 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | 36 551 680.7 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
373.8B USD | 6.6 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
168.4B USD | 5 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
138.9B USD | 4.8 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
129.7B USD | 11.8 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 1 927.4 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
121.1B AUD | 5 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73.1B USD | 5.1 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 18.6 |
|
NL |
![]() |
argenx SE
XBRU:ARGX
|
32.9B EUR | 16.3 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
US |
![]() |
Taysha Gene Therapies Inc
NASDAQ:TSHA
|
Average P/S:
3 323 065.8
42.3
|
75%
|
0.6 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
36 551 680.7
|
N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
6.6
|
8%
|
0.8 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
5
|
4%
|
1.3 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
4.8
|
3%
|
1.6 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
11.8
|
10%
|
1.2 |
|
US |
E
|
Epizyme Inc
F:EPE
|
1 927.4
|
N/A | N/A |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
5
|
7%
|
0.7 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
5.1
|
7%
|
0.7 |
|
US |
S
|
Seagen Inc
F:SGT
|
18.6
|
30%
|
0.6 |
|
NL |
![]() |
argenx SE
XBRU:ARGX
|
16.3
|
37%
|
0.4 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.